This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PharMerica Reports Fourth Quarter And Full Year 2013 Results

PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the fourth quarter and full year ended December 31, 2013.

Fourth Quarter 2013 Highlights (Comparisons to Fourth Quarter 2012)

  • Adjusted diluted earnings per share of $0.44, an increase of 22%
  • Cash flows from operating activities of $3.7 million
  • Adjusted EBITDA of $30.6 million, an increase of 6%
  • Generic dispensing rate increased to industry-leading 83.7%
  • Strategic investment in Onco360 to expand PharMerica’s presence in the rapidly growing oncology market
  • Partnership with Innovatix to advance PharMerica’s position in the home infusion and specialty market

Full Year 2013 Highlights (Comparisons to Full Year 2012)

  • Record adjusted diluted earnings per share of $1.83, an increase of 30%
  • Record cash flows from operating activities of $155.7 million, an increase of 82%
  • Record adjusted EBITDA of $132.8 million, an increase of 19%

Greg Weishar, PharMerica Corporation’s Chief Executive Officer, said, “2013 was a record year for PharMerica. Our results underscore continued progress in core operations, profitability and cash flows. We are making great progress in the long-term care business, diversifying revenues and enhancing shareholder value.

“During the fourth quarter, excluding previously disclosed bed losses, we achieved net sales growth which we anticipate will continue throughout 2014. We continue to enhance our industry leading position in generic dispensing, and we are making solid progress in deploying innovative products and services that save clients money. Further, in 2014 we intend to advantageously deploy cash flow from operating activities to support ongoing strategic purchasing initiatives. Collectively, we anticipate all these efforts will position the Company for 2015 and beyond.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,982.59 +22.02 0.13%
S&P 500 1,978.91 +0.57 0.03%
NASDAQ 4,444.9090 -4.6550 -0.10%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs